Zydus Lifesciences receives Mexican regulatory approval to market Mamitra, a Trastuzumab biosimilar for breast and gastric cancer treatment, expanding its biosimilar portfolio.

India Ratings & Research (Ind-Ra) has revised its GDP growth forecast for FY25 to 7.5%, citing improved consumption demand. The agency expects PFCE to grow to 7.4% in FY25.

Omaxe shares hit lower circuit after Sebi barred the company, its Chairman, MD, and three others from the securities market for two years due to irregularities in financial statements.

The Indian Jute Mills Association raised concerns about declining demand for jute bags and other challenges faced by the industry at the 32nd SAC meeting in New Delhi.

The Bank of Japan raised its key interest rate to 0.25% from 0.1%, aiming to curb the yen's slide against the US dollar. The move comes amid rising inflation and a weak yen.

Congress leader Mallikarjun Kharge demanded the expunging of 'parivarvaad' remarks made against him by BJP MP Ghanshyam Tiwari in the Rajya Sabha. The Chairman assured to review the remarks.

Zydus Lifesciences receives Mexican regulatory approval to market Mamitra, a Trastuzumab biosimilar for breast and gastric cancer treatment, expanding its biosimilar portfolio.

India Ratings & Research (Ind-Ra) has revised its GDP growth forecast for FY25 to 7.5%, citing improved consumption demand. The agency expects PFCE to grow to 7.4% in FY25.

India has been elected as vice-chair of the supply chain council under the Indo-Pacific Economic Framework (IPEF), signifying its growing role in regional economic cooperation.

Granules India's shares soared nearly 7% after the company reported a significant increase in net profit for the June quarter. The stock hit a 52-week high on strong earnings.